Misoprostol Exelgyn (Misoprostol)

Misoprostol mimics prostaglandin E1 and binds to EP receptors on gastric and uterine tissues. In the stomach, this binding increases protective mucus and bicarbonate while reducing acid secretion. In the uterus, it raises intracellular calcium, leading to smooth‑muscle contraction and cervical softening.

The dose of Misoprostol Exelgyn is determined by the prescribing healthcare professional based on the specific indication, patient weight, gestational age (for obstetric use), and any concomitant medications. Only a qualified prescriber should set the regimen.

Misoprostol is contraindicated in pregnancy except when used intentionally for termination or labor induction under medical supervision. Its safety during breastfeeding has not been established, so clinicians should weigh potential risks and benefits before prescribing.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Misoprostol is a prostaglandin analogue that can be administered orally, offering convenience compared with injectable agents like oxytocin. It has a well‑characterised safety profile but may cause more gastrointestinal side effects. Choice of agent depends on clinical setting, route preference and patient-specific factors.

Misoprostol Exelgyn should be stored at temperatures below 25 °C, in its original packaging, protected from moisture, heat and direct light. Maintaining these conditions helps preserve potency and stability throughout its shelf life.

The product is supplied for oral administration. It is taken with water, usually on an empty stomach for gastric‑ulcer prevention, or as directed by a clinician for obstetric indications. Exact timing and dosing schedule are determined by the prescriber.

Serious risks include uterine rupture, severe postpartum hemorrhage, anaphylactic reactions, cardiovascular collapse, and severe abdominal pain indicating possible perforation. Patients should be monitored closely for these events, especially when used for labor induction or abortion.

Misoprostol Exelgyn is contraindicated in patients with known hypersensitivity to misoprostol or other prostaglandins, in women with a viable intrauterine pregnancy when not intended for termination, and in individuals with severe cardiac, hepatic or renal disease where uterine hyperstimulation could be hazardous.